Table 2 D. ’Amico risk stratification for prostate cancer.
Risk group† | T stage | Gleason score (combined) | PSA (ng/mL) |
---|---|---|---|
Low-risk | T1-2a | ≤6 | <10 |
Intermediate-risk | T2b | 7 | 10–20 |
High-risk | ≥T2c | ≥8 | >20 |
†, risk based on highest risk subcategory; current risk-stratification based on NCCN modifies high-risk T stage to T3a or higher. PSA, prostate-specific antigen; NCCN, National Comprehensive Cancer Network.